Pharmaceutical - Pacira Pharmaceuticals, Research

Filter

Popular Filters

Exparel Ph III trial in intercostal nerve block fails to meet primary endpoint

02-08-2013

USA-based Pacira Pharmaceuticals (Nasdaq: PCRX) has reported results from its second pivotal, Phase III…

ExparelNeurologicalPacira PharmaceuticalsPharmaceuticalResearch

Parexel

Parexel

Back to top